Texas Ibogaine Initiative funding push
The guests describe a 2025 campaign to get Texas to fund ibogaine drug development. They say Texas moved from a proposed $50 million effort to a fully state-funded $100 million initiative.
#2477 - Rick Perry & W. Bryan Hubbard
Source description
Rick Perry is the former Governor of Texas and former U.S. Secretary of Energy. W. Bryan Hubbard is the Chief Executive Officer of Americans for Ibogaine, a public policy education and advocacy organization working to medicalize ibogaine in the United …
Rick Perry is the former Governor of Texas and former U.S. Secretary of Energy. W. Bryan Hubbard is the Chief Executive Officer of Americans for Ibogaine, a public policy education and advocacy organization working to medicalize ibogaine in the United States.www.americansforibogaine.org/joe Perplexity: Download the app or ask Perplexity anything at https://pplx.ai/rogan. This video is sponsored by BetterHelp. Visit https://BetterHelp.com/JRE Learn more about your ad choices. Visit podcastchoices.com/adchoices
Key Topics
- Texas Ibogaine Initiative funding push
- Legislative strategy and last-minute approval
- Veteran advocates and personal testimonies
- What ibogaine is and where it comes from
- Addiction interruption claims
- Traumatic brain injury and PTSD focus
- Stanford imaging and brain-normalization narrative
- Neuroplasticity time-window comparisons
- Ibogaine experience and side effects
- Americans for Ibogaine organization growth
- Rick Perry’s motivation and reputation risk
- Political evolution on reform issues
- War on drugs and Schedule I critique
- Opioid crisis and Purdue Pharma condemnation
- Claims of high efficacy rates
- Broader trauma cases beyond veterans
- CTE and contact-sport interest
- Faith framing and Christian outreach
- Scriptural and historical psychedelic interpretations
- Spiritual famine and emancipation rhetoric
- AI, abundance, and governance critique
- Docuseries and media narrative shift
- Institutional partnerships for research
- Resource constraints and treatment bottlenecks
- Perry’s personal treatment and brain-scan claims
- Rogan’s openness to treatment
- Cautious discussion of Parkinson’s anecdote
- Multi-state coalition building
- ALEC endorsement and model legislation
- State-by-state bill updates
- Mississippi opioid fund appropriation
- Gabon partnership and supply significance
- Native American tribal involvement and sovereignty questions
- Right to Try law and DEA interpretation dispute
- Rescheduling push and presidential role
- Clinical trial urgency and “moonshot” framing
- Public distrust, trauma, and civic decline themes
- Kentucky opioid commission story and “Tamara” narrative
- Attack on Andy Beshear and Purdue-linked politics
- Changing minds through curiosity and humility
- Regional stereotypes and hookworm explanation
- Media avoidance and everyday social trust
- Iboga plant variability and “imposter” shrub story
- Closing patriotic and spiritual manifesto
Legislative strategy and last-minute approval
They recount winning overwhelming legislative support but needing late intervention from top state leaders. They credit a May 14, 2025 meeting and a May 16 confirmation from Lt. Gov. Dan Patrick as decisive.
Veteran advocates and personal testimonies
Marcus and Morgan Luttrell are presented as key messengers who shared firsthand experiences. Their stories are framed as pivotal in persuading skeptical officials to engage.
What ibogaine is and where it comes from
Ibogaine is described as an alkaloid derived from the iboga shrub, associated with Gabon and Bwiti traditions. The discussion positions it as non-recreational and historically used in spiritual contexts.
Addiction interruption claims
They claim ibogaine can rapidly interrupt physiological dependence on opioids and other substances. They also suggest benefits for compulsive behaviors tied to dopamine-driven reinforcement.
Traumatic brain injury and PTSD focus
The conversation centers on veterans seeking ibogaine abroad for treatment-resistant depression, anxiety, and suicidality. They cite early research interest in neuroregeneration and symptom relief.
Stanford imaging and brain-normalization narrative
They discuss functional MRI findings they attribute to Stanford-related work, describing a shift from “addicted” patterns to “normal” within days. These results are used to argue for urgent U.S. clinical trials.
Neuroplasticity time-window comparisons
Rick Perry references a talk comparing neuroplasticity windows across ketamine, psilocybin, and ibogaine. Ibogaine is portrayed as having a longer period for retraining and recovery support.
Ibogaine experience and side effects
They emphasize the experience is intense and physically unpleasant, including prolonged nausea and immobility. The severity is framed as one reason it is not a casual or party drug.
Americans for Ibogaine organization growth
They describe Americans for Ibogaine as an advocacy and policy group that expanded from a small board to a national ambassador network. The goal is to seed state-level support and a unified drug development pathway.
Rick Perry’s motivation and reputation risk
Perry frames his involvement as driven by witnessing veterans near suicide and feeling a moral obligation to help. He says saving lives matters more than protecting his political reputation.
Political evolution on reform issues
Perry recounts shifting from “tough on crime” to supporting criminal justice reform in Texas. He uses this as an analogy for changing views on psychedelics based on evidence and outcomes.
War on drugs and Schedule I critique
They criticize Schedule I classifications as politically motivated and scientifically outdated. Nixon-era narratives are blamed for restricting research and access despite perceived medical promise.
Opioid crisis and Purdue Pharma condemnation
Perry describes oxycodone marketing as catastrophic and morally wrong. Opioids are framed as a driver of addiction, overdose, and downstream trauma in families and communities.
Claims of high efficacy rates
They cite dramatic success figures for opioid addiction relief within 48 to 72 hours and higher rates with repeated dosing. These claims are contrasted with low success rates in abstinence-only models.
Broader trauma cases beyond veterans
The guests share stories of survivors of sexual abuse, first responders, and others reporting major improvements after ibogaine. The anecdotes are used to argue for wider therapeutic relevance.
CTE and contact-sport interest
They discuss potential applications for chronic traumatic encephalopathy and repeated concussions. Professional athletes are mentioned as an emerging group seeking treatment and advocacy.
Faith framing and Christian outreach
Psychedelics are discussed as compatible with Christian theology for some believers. A forthcoming book, “A Christian’s Guide to Psychedelics,” is cited as a bridge to skeptical religious audiences.
Scriptural and historical psychedelic interpretations
They reference theories linking biblical stories to psychoactive plants, including the burning bush as acacia and DMT. They also mention Allegro’s thesis about psychedelic use in early Christianity.
Spiritual famine and emancipation rhetoric
Hubbard frames ibogaine and psychedelics as catalysts for spiritual renewal in a society he describes as alienated and traumatized. He links this to autonomy, dignity, and resistance to abusive power.
AI, abundance, and governance critique
Hubbard connects future AI-driven abundance to the need for social cohesion and ethical governance. He warns that broken institutions could steer technology toward dystopia without a spiritual reawakening.
Docuseries and media narrative shift
They mention a planned multi-part docuseries about psychedelics and meaning-making. The broader point is that information access is accelerating cultural change and reducing gatekeeping.
Institutional partnerships for research
Perry describes a collaboration involving the Center for BrainHealth at UT Dallas, Americans for Ibogaine, and a funder group. The study aims to answer who benefits, for how long, and what brain changes occur.
Resource constraints and treatment bottlenecks
They note high demand for clinics in Mexico and limited openings for veteran-focused organizations. The surge is framed as both a challenge and proof of unmet need.
Perry’s personal treatment and brain-scan claims
Perry describes undergoing ibogaine and reporting improved sleep and reduced anxiety. He recounts brain imaging changes, including increased prefrontal activity and reduced atrophy, as persuasive evidence to him.
Rogan’s openness to treatment
Rogan is asked about cumulative concussions and potential preventive interest. He says he would be willing to undergo ibogaine treatment and is fascinated by the reports.
Cautious discussion of Parkinson’s anecdote
Hubbard shares a story of a woman with young-onset Parkinson’s reporting restored function after treatment. He adds qualifiers about disease subtype, timing, and the claim being at the edge of science.
Multi-state coalition building
They describe recruiting officials from many states to align with Texas in a unified FDA drug development effort. Aspen meetings and outreach to state legislatures are presented as key steps.
ALEC endorsement and model legislation
They say ALEC, traditionally aligned with stricter drug policy, adopted a supportive position and model bill after hearing their case. This is presented as a major political signal for conservative legislatures.
State-by-state bill updates
They list active or passed measures in Tennessee, Missouri, Oklahoma, Louisiana, Kentucky, West Virginia, and Mississippi. The bills are framed as mechanisms to join a Texas-led development trial and funding stream.
Mississippi opioid fund appropriation
Mississippi is highlighted as committing money from an opioid fund to support the effort. The signing and ceremonial emphasis are presented as symbolically important for the state’s history.
Gabon partnership and supply significance
Hubbard says Gabon named their organization an official partner for advancing iboga globally. The discussion underscores origin-country relationships and the plant’s cultural and ecological context.
Native American tribal involvement and sovereignty questions
They discuss the Choctaw Nation exploring participation and an intertribal council resolution. Rogan asks whether tribal sovereignty could enable earlier access, and they note legal uncertainty and supply-chain limits.
Right to Try law and DEA interpretation dispute
They argue that federal Right to Try should apply once phase-one safety is completed. They claim the DEA excludes Schedule I substances by interpretation, and they call for policy reversal.
Rescheduling push and presidential role
They argue ibogaine should move off Schedule I and suggest executive leadership is essential. The president is framed as the key actor who could accelerate research, rescheduling, and interagency support.
Clinical trial urgency and “moonshot” framing
They repeatedly characterize ibogaine approval as a near-term national moonshot. Texas funding is used to justify a timeline of roughly three years for major progress through FDA processes.
Public distrust, trauma, and civic decline themes
Hubbard links addiction, suicide, and institutional corruption to collapsing trust in government. He portrays the movement as a humanitarian and moral response to widespread despair.
Kentucky opioid commission story and “Tamara” narrative
Hubbard recounts town halls where grief and distrust dominated public feedback. A story of a child abuse survivor later jailed for opioid possession is used to criticize punitive responses to trauma.
Attack on Andy Beshear and Purdue-linked politics
Hubbard launches a detailed political critique of Kentucky Governor Andy Beshear and his father. He alleges ties to Purdue Pharma litigation outcomes and uses this to argue for accountability and public skepticism.
Changing minds through curiosity and humility
Rogan and Perry emphasize curiosity as a core virtue for updating beliefs. They argue people should separate identity from opinions and accept being wrong as growth.
Regional stereotypes and hookworm explanation
Rogan discusses stereotypes about Southern accents and intelligence. He offers a historical explanation involving hookworm prevalence affecting energy and cognition, and they use it to caution against bias.
Media avoidance and everyday social trust
Hubbard describes avoiding TV news and finding daily life safer and more community-oriented than portrayed. He urges direct conversation with strangers as an antidote to manufactured division.
Iboga plant variability and “imposter” shrub story
They describe iboga varietals and differences by region, likening it to wine terroir. A story is shared about a poisonous look-alike plant that resembles iboga until maturity, highlighting identification risks.
Closing patriotic and spiritual manifesto
Hubbard ends with a sweeping speech about American decline, mass death, and a mission to affirm human divinity. The rhetoric frames the movement as moral renewal tied to national purpose and liberation.